Tevogen Bio Holdings Inc. (TVGN) - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed on April 29, 2024, by Tevogen Bio Holdings Inc., a Delaware corporation and emerging growth company. The filing reports a change in the registrant's certifying accountant effective immediately for the fiscal year ending December 31, 2024. The Company completed a business combination with Tevogen Bio Inc. on February 14, 2024.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. The document focuses exclusively on the appointment and dismissal of independent registered public accounting firms.
Material Changes
- Appointment of New Auditor: KPMG LLP was appointed as the independent registered public accounting firm, replacing Marcum LLP.
- Dismissal of Prior Auditor: Marcum LLP was dismissed as the independent registered public accounting firm.
- Audit History: Marcum's reports for fiscal years 2022 and 2023 included an explanatory paragraph regarding the Company's ability to continue as a going concern but did not contain an adverse opinion, disclaimer, or qualification.
- Internal Controls: The Company previously disclosed in its 2023 Form 10-K that internal control over financial reporting was not effective as of December 31, 2023, due to a material weakness related to accounting for complex financial instruments and controls over collectability from related parties.
Guidance, Risks, and Contingencies
The filing does not contain forward-looking guidance, management commentary on future operations, or new risk factors beyond the previously disclosed material weakness in internal controls. The Company confirmed there were no disagreements with Marcum regarding accounting principles or audit scope during the two most recent fiscal years and the subsequent interim period.
Investor Verification Checklist
- Verify the status of the material weakness in internal controls over financial reporting disclosed in the 2023 Annual Report.
- Review the letter from Marcum LLP (Exhibit 16.1) to confirm their agreement with the Company's statements regarding the dismissal.
- Monitor upcoming financial statements audited by KPMG for the fiscal year ending December 31, 2024.
- Assess the impact of the "going concern" explanatory paragraph noted in prior audits on current liquidity and solvency.